Psoriasis Clinical Trials

Current / Recent Psoriasis Clinical Trials.  Click title to view trial details.

1. Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
2.  Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
3.  Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
4. Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
5. A Post Marketing Observational Study (PMOS) of the Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biological Disease Modifying Anti-rheumatic Drugs (BDMARDs) Over 1 Year
6. Prevalence of Sleep Disturbances in Psoriasis
7. Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
8. Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
9. Peds Metabolic Syndrome in Psoriasis
10. A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
11. A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
12. The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
13. Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
14. Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
15. Psoriasis Longitudinal Assessment and Registry (PSOLAR)
16. Premature Coronary Artery Disease (CAD) in Severe Psoriasis
17. CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.
18. A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
19. Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
20. Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
21. A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
22. Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
23. A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
24. Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis
25. Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
26. Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
27. Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
28. Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
29. Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
30. A Study for Adults With Plaque Psoriasis
31. A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
32. A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies
33. A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
34. Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
35. Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
36. Adalimumab in Adult Japanese Subjects With Psoriasis
37. Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
38. Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
39. A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
40. Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
41. Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
42. A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
43. Double-Blind, Randomized, Placebo-Controlled Comparison of CC10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
44. A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
45. Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
46. Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
47. Randomized Study of PH-10 for Psoriasis
48. A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
49. AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis
50. Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
51. A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
52. A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
53. A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis.
54. A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
55. Raptiva in Palm and Sole Psoriasis
56. Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
57. Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
58. Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
59. A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
60. Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)